Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
466.51 x 1 491.00 x 1
Post-market by (Cboe BZX)
474.62 -9.39 (-1.94%) 04/04/25 [NASDAQ]
466.51 x 1 491.00 x 1
Post-market 474.62 unch (unch) 16:49 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
473.64
Day High
499.07
Open 484.35
Previous Close 484.01 484.01
Volume 2,884,400 2,884,400
Avg Vol 1,503,090 1,503,090
Stochastic %K 19.73% 19.73%
Weighted Alpha +13.07 +13.07
5-Day Change -18.07 (-3.67%) -18.07 (-3.67%)
52-Week Range 377.85 - 519.88 377.85 - 519.88
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,288,928
  • Shares Outstanding, K 256,790
  • Annual Sales, $ 11,020 M
  • Annual Income, $ -535,600 K
  • EBIT $ -233 M
  • EBITDA $ -26 M
  • 60-Month Beta 0.50
  • Price/Sales 11.27
  • Price/Cash Flow N/A
  • Price/Book 7.59

Options Overview Details

View History
  • Implied Volatility 37.16% ( +4.11%)
  • Historical Volatility 19.24%
  • IV Percentile 90%
  • IV Rank 55.20%
  • IV High 52.99% on 12/18/24
  • IV Low 17.64% on 05/16/24
  • Put/Call Vol Ratio 0.79
  • Today's Volume 2,566
  • Volume Avg (30-Day) 1,792
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 36,454
  • Open Int (30-Day) 35,645

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.68
  • Number of Estimates 8
  • High Estimate 3.99
  • Low Estimate 3.27
  • Prior Year 4.29
  • Growth Rate Est. (year over year) -14.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
471.50 +0.66%
on 03/31/25
Period Open: 486.22
519.68 -8.67%
on 03/14/25
-11.60 (-2.39%)
since 03/04/25
3-Month
397.24 +19.48%
on 01/13/25
Period Open: 407.11
519.68 -8.67%
on 03/14/25
+67.51 (+16.58%)
since 01/03/25
52-Week
377.85 +25.61%
on 12/19/24
Period Open: 404.01
519.88 -8.71%
on 11/08/24
+70.61 (+17.48%)
since 04/04/24

Most Recent Stories

More News
Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.

Which group of individuals is in the best position to spot early warning signs of economic trouble? There's a good case to be made for corporate chief financial officers (CFOs). These executives know how...

D : 52.73 (-6.26%)
VRTX : 474.62 (-1.94%)
WMT : 83.19 (-4.66%)
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

SRPT : 54.43 (-7.13%)
BMRN : 60.26 (-10.70%)
VRTX : 474.62 (-1.94%)
MRNA : 25.11 (-2.41%)
AMGN : 294.39 (-4.99%)
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies

The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.

TECH : 51.72 (-5.72%)
VRTX : 474.62 (-1.94%)
MRNA : 25.11 (-2.41%)
REGN : 573.45 (-6.09%)
XBI : 73.66 (-5.73%)
10 Stocks of the S&P 500 ETF Up More Than 20% in Q1

The S&P 500 wrapped up the worst quarter since the third quarter of 2022, plunging 4.6%, due to escalating trade tensions and concerns over stagflation.The Trump administration imposed tariffs on Canada,...

CVS : 63.66 (-5.70%)
T : 26.64 (-6.85%)
WRB : 65.43 (-6.91%)
WELL : 143.29 (-6.00%)
NEM : 44.18 (-8.59%)
COR : 278.39 (-3.79%)
VRTX : 474.62 (-1.94%)
GILD : 107.25 (-4.57%)
PM : 150.62 (-7.06%)
SPY : 505.28 (-5.85%)
ED : 109.32 (-3.02%)
Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

The economy has been on shaky ground for a while, and President Trump's tariffs and trade wars could finally send it into a recession. That's a big concern for the market these days as consumers have been...

NFLX : 855.86 (-6.67%)
VRTX : 474.62 (-1.94%)
ROST : 130.31 (-0.69%)
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

BMRN : 60.26 (-10.70%)
VRTX : 474.62 (-1.94%)
MRNA : 25.11 (-2.41%)
UTHR : 292.46 (-4.85%)
BIIB : 122.98 (-5.91%)
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this....

COMP : 8.28 (-1.78%)
VRTX : 474.62 (-1.94%)
DXCM : 59.83 (-3.19%)
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

MYGN : 8.13 (-3.33%)
VRTX : 474.62 (-1.94%)
BMRN : 60.26 (-10.70%)
GILD : 107.25 (-4.57%)
MRNA : 25.11 (-2.41%)
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility .

NVO : 62.55 (-6.78%)
VRTX : 474.62 (-1.94%)
LLY : 738.21 (-6.45%)
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Many investors view the healthcare sector as a safe haven when the stock market is turbulent. That's understandable. The demand for healthcare products and services typically holds up very well regardless...

KNSA : 20.36 (-6.43%)
VRTX : 474.62 (-1.94%)
AGN.AX : 0.750 (-0.66%)
ABBV : 186.96 (-7.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 516.68
2nd Resistance Point 507.87
1st Resistance Point 491.25
Last Price 474.62
1st Support Level 465.82
2nd Support Level 457.01
3rd Support Level 440.39

See More

52-Week High 519.88
Last Price 474.62
Fibonacci 61.8% 465.62
Fibonacci 50% 448.86
Fibonacci 38.2% 432.11
52-Week Low 377.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades